Format

Send to

Choose Destination
P T. 2017 Aug;42(8):502-504.

Pharmaceutical Approval Update.

Abstract

Naldemedine (Symproic) for opioid-induced constipation; deutetrabenazine (Austedo) for chorea associated with Huntington's disease; and infliximab-abda (Renflexis), a Remicade biosimilar, for the treatment of Crohn's disease, rheumatoid arthritis, and other diseases.

PMID:
28781502
PMCID:
PMC5521297

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center